Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBT Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBT Margin for 2 consecutive years, with 5514.74% as the latest value for Q1 2024.

  • Quarterly EBT Margin changed N/A to 5514.74% in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 24675.3% through Dec 2024, changed N/A year-over-year, with the annual reading at 26045.02% for FY2024, 2595948.0% down from the prior year.
  • EBT Margin for Q1 2024 was 5514.74% at Artiva Biotherapeutics, down from 563.87% in the prior quarter.
  • The five-year high for EBT Margin was 563.87% in Q4 2023, with the low at 5514.74% in Q1 2024.